According to Natera's latest financial reports and stock price the company's current number of shares outstanding is 134,750,000. At the end of 2025 the company had 134,750,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2025 | 0.13 B | 8.87% |
2024 | 0.12 B | 7.47% |
2023 | 0.11 B | 18.67% |
2022 | 97.05 M | 4.86% |
2021 | 92.55 M | 14.4% |
2020 | 80.9 M | 14.83% |
2019 | 70.45 M | 16.32% |
2018 | 60.57 M | 13.33% |
2017 | 53.44 M | 2.76% |
2016 | 52.01 M | 15.73% |
2015 | 44.94 M | 22.51% |
2014 | 36.68 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Prothena PRTA | 53,827,000 | -60.05% | ๐ฎ๐ช Ireland |
![]() Paratek Pharmaceuticals
PRTK | 57,282,239 | -57.49% | ๐บ๐ธ USA |
![]() Vertex Pharmaceuticals VRTX | 256,900,000 | 90.65% | ๐บ๐ธ USA |